Accelerate and transform discovery research and capitalize on the diverse opportunities of the microbiome with Diversigen.
With years of experience, flexible sequencing, and bioinformatic capacity, we address unique customer needs, like designing custom sampling techniques, handling low biomass or dirty samples, employing sensitive levels of QA/QC or crafting unique study design.
Diversigen has extensive experience with highly diverse microbiome sample types and provides full project life cycle consulting services, building on research conducted at Baylor College of Medicine in the Alkek Center for Metagenomics and Microbiome Research .
Phase I Clinical Trial Generates Data on Mechanism of Action, Safety and Tolerability
4D pharma plc, a pharmaceutical company focusing on the development of live biotherapeutics, today provides the following update on the phase 1 clinical trial in respect of Blautix, its proprietary single strain live biotherapeutic for the treatment of Irritable Bowel Syndrome (IBS). Read More
This paper provides an introduction to microbiome-based biomarkers and the application of biomarkers enabling targeted therapies, the role biomarkers play in reimbursement decisions for new therapies, an example process for biomarker identification/validation and more. Get Paper